Nicole LaBrosse - Feb 16, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 16, 2024
Transactions value $
-$202,196
Form type
4
Date filed
2/20/2024, 06:53 PM
Previous filing
Feb 16, 2024
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5.09K +47.78% $0.00 15.8K Feb 16, 2024 Direct
transaction HALO Common Stock Tax liability -$98.8K -2.74K -17.38% $36.10 13K Feb 16, 2024 Direct F1
transaction HALO Common Stock Options Exercise $0 +5.33K +40.95% $0.00 18.3K Feb 16, 2024 Direct
transaction HALO Common Stock Tax liability -$103K -2.86K -15.61% $36.10 15.5K Feb 16, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5.09K -33.33% $0.00 10.2K Feb 16, 2024 Common Stock 5.09K $0.00 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -5.33K -25% $0.00 16K Feb 16, 2024 Common Stock 5.33K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,737 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 2,864 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.